Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Multiplexed analytical approaches to beta-lactam allergy in vitro testing standardization

  • Juárez-Rodríguez, María José
  • Ibáñez-Echevarría, Ethel
  • Hernández-Fernández de Rojas, Dolores
  • Maquieira, Angel|||0000-0003-4641-4957
  • Morais, Sergi|||0000-0002-3722-2358
[EN] The suspicion of beta-lactam allergy directly contributes to the prescription of antibiotics that diverge from the guidelines, increasing antimicrobial resistance, one of the biggest threats to global health. In vitro quantification of specific IgE is very useful for monitoring allergy, as it confirms or rules out immediate beta-lactam drug allergy and helps find safe alternative antibiotic stewardship. However, reliable in vitro quantification of specific IgE to beta-lactam antibiotics by immunoassay is challenging because of the difficulty of having selective immunoreagents, mainly beta-lactam antigens, and its low concentration levels in serum. Thus, reliable and sensitive in vitro tests for multiplex detection of allergy to different beta-lactam antibiotics is currently essential for clinical diagnosis. Nevertheless, the lack of standardization of quantitative in vitro methods makes the comparison and interpretation of the results difficult. Here, as proof of concept, we report an improved multiplex microimmunoassay for beta-lactam allergy in vitro testing standardization. The results revealed that homologous calibration allows reliable quantification of specific IgE in human serum at very low concentrations (144 ng L-1). Moreover, the reproducibility of the results increases 2-fold using an internal standard, achieving accurate quantitative information: 93% and 106% recovery for penicillin and amoxicillin, respectively. We simultaneously evaluated the reliability of the improved multiplexed in vitro method in a cohort of 40 human serum samples and achieved excellent agreement (0.99) with a currently used in vitro test., M.J.J acknowledges financial support from the FPIprogram from Universitat Politecnica de Valencia. This research was supported by the H2020 program (project COBIOPHAD, grant agreement No. 688448) , being an initiative of the Photonics Public Private Partnership; Agencia Estatal de Investigacian (PID2019-110713RB-I0 0, FEDER) ; program UPVLa FE 2019 (P105 VALBIOAL).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Boosting the sensitivity of in vitro b-lactam allergy diagnostic tests

  • Peña-Mendizábal, Edurne
  • Morais, Sergi|||0000-0002-3722-2358
  • Maquieira, Angel|||0000-0003-4641-4957
[EN] The synthesis of structurally new haptens and the development of suitable antigens are essential for boosting the sensitivity of drug allergy diagnostic testing. Unprecedented structural antigens for benzylpenicillin and amoxicillin are characterised and evaluated in a cohort of 70 subjects with a turnkey solution based on consumer electronics., This work was funded by the H2020 program (project COBIOPHAD, grant agreement No. 688448), an initiative of the Photonics Public Private Partnership; Agencia Estatal de Investigacion (CTQ2016-75749-R, FEDER) and program UPV-La FE 2019 (PI05 VALBIOAL). E. P. M. holds a FPU doctoral fellowship from Ministerio de Educación, Cultura y Deporte.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Reversed-phase allergen microarrays on optical discs for multiplexed diagnostics of food allergies

  • Tortajada-Genaro, Luis Antonio|||0000-0003-4021-5607
  • Morais, Sergi|||0000-0002-3722-2358
  • Maquieira, Angel|||0000-0003-4641-4957
  • Casañ-Raga, Natalia
  • Mas, Salva
  • Ibañez-Echevarria, Ethel
[EN] A high percentage of the population suffers from multiple food allergies justifying the importance of reliable diagnostic methods. Single-analyte solutions based on the determination of specific immunoglobulins E (sIgE) are safe and fast but are generally time-consuming and expensive. Thus sustainable microanalytical methods that provide multianalyte profiling information are highly demanded. This work presents the in vitro biosensing of specific IgE levels based on a reversed-phase allergen array. The approach consists of optical biosensing supported by direct multiplex immunoassays and on-disc technology. It identifies 12 sIgE associated with food allergies in a single analysis with a low serum sample volume (25 ¿L). After processing captured images, specific signals for each target biomarker correlate to their concentration. The assay analytically performs well with 0.3 IU/mL and 0.41 IU/mL as the detection and quantification limits in serum, respectively. This novel method achieves excellent clinical specificity (100%) and high sensitivity (91.1%), considering the diagnosis obtained by clinical history and ImmunoCAP analysis. The results demonstrate that microanalytical systems based on allergen arrays can potentially diagnose multiple food allergies and are easily implemented in primary care laboratory settings., Program UPV-La Fe 2019 (PI05 VALBIOAL) and grant PID2019-110713RB-I00 funded by MCIN/AEI/https://doi.org/10.13039/501100011033 and by "ERDF A way of making Europe." The Generalitat Valenciana also supported this research (PROME-TEO/2020/094, Proyecto "88/2021").
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Standardizing In Vitro beta-Lactam Antibiotic Allergy Testing with Synthetic IgE

  • Quintero-Campos, Pedro|||0000-0002-9398-5077
  • Maquieira, Angel|||0000-0003-4641-4957
  • Morais, Sergi|||0000-0002-3722-2358
  • Gozalbo-Rovira, Roberto
  • Rodríguez-Díaz, Jesús
[EN] The global prevalence of ß-lactam allergy poses a major challenge in administering first-line antibiotics, such as penicillins, to a significant portion of the population. The lack of ß-lactam IgE antibody pools with defined selectivity hampers the standardization and validation of in vitro assays for ß-lactam allergy testing. To address this limitation, this study introduces a synthetic IgE specific to ß-lactam antibiotics as a valuable tool for drug allergy research and diagnostic tests. Using phage display technology, we constructed a library of human single-chain antibody fragments (scFv) to target the primary determinant of amoxicillin, a widely used ß-lactam antibiotic. Subsequently, we produced a complete human synthetic IgE molecule using the highly efficient baculovirus expression vector system. This synthetic IgE molecule served as a standard in an in vitro chemiluminescence immunoassay for ß-lactam antibiotic allergy testing. Our results demonstrated a detection limit of 0.05 IU/mL (0.63 pM), excellent specificity (100%), and a four-fold higher clinical sensitivity (73%) compared to the in vitro reference assay when testing a cohort of 150 serum samples. These findings have significant implications for reliable interlaboratory comparison studies, accurate labeling of allergic patients, and combating the global public health threat of antimicrobial resistance. Furthermore, by serving as a valuable trueness control material, the synthetic IgE facilitates the standardization of diagnostic tests for ß-lactam allergy and demonstrates the potential of utilizing this synthetic strategy as a promising approach for generating reference materials in drug allergy research and diagnostics., P.Q.-C. acknowledges financial support from Generalitat Valenciana through the research staff-training program (GVA ACIF/2018/173). S.M. acknowledges grant PID2019-110713RB-I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe . PROMETEO/2020/094 funded by Generalitat Valenciana, program UPV-La FE 2019 (P105 VALBIOAL), the H2020 program (COBIOPHAD project, grant agreement No. 688448). J.R.-D. acknowledges grant PID2020-115403RBC22 funded by MICIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe .
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam

  • Peña-Mendizábal, Edurne
  • Morais, Sergi|||0000-0002-3722-2358
  • Maquieira, Angel|||0000-0003-4641-4957
[EN] New antigens deriving from -lloyl and -llanyl, major and minor determinants, respectively, were produced for beta-lactam antibiotics cefuroxime, cefotaxime, ceftriaxone, meropenem and aztreonam. Twenty beta-lactam antigens were produced using human serum albumin and histone H1 as carrier proteins. Antigens were tested by multiplex in vitro immunoassays and evaluated based on the detection of specific IgG and IgE in the serum samples. Both major and minor determinants were appropriate antigens for detecting specific anti-beta-lactam IgG in immunised rabbit sera. In a cohort of 37 allergic patients, we observed that only the minor determinants (-llanyl antigens) were suitable for determining specific anti-beta-lactam IgE antibodies with high sensitivity (<0.01 IU/mL; 24 ng/L) and specificity (100%). These findings reveal that not only the haptenisation of beta-lactam antibiotics renders improved molecular recognition events when the 4-member beta-lactam ring remains unmodified, but also may contribute to develop promising minor antigens suitable for detecting specific IgE-mediated allergic reactions. This will facilitate the development of sensitive and selective multiplexed in vitro tests for drug-allergy diagnoses to antibiotics cephalosporin, carbapenem and monobactam., This work has been funded by the H2020 programme (Project COBIOPHAD, grant agreement No. 688448), and is an initiative of the Photonics Public Private Partnership (www.photonics21.org); Agencia Estatal de Investigacion (CTQ2016-75749-R, FEDER) and programme UPV-LA FE 2019 (PI05 VALBIOAL). The authors acknowledge the Instituto de Investigacion Sanitaria La Fe, Valencia, Spain, which provided the samples from both allergic patients and controls. E.P.M acknowledges an FPU grant from the Ministerio de Educacion, Cultura y Deporte.